Roberts Glore & CO Inc Pfizer Inc Transaction History

Roberts Glore & CO Inc

$341 Million
Q3 2024

A detailed history of Roberts Glore & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Roberts Glore & CO Inc holds 39,344 shares of PFE stock, worth $988,714. This represents 0.33% of its overall portfolio holdings.

Number of Shares

39,344

Previous 39,526 0.46%

Holding current value

$988,714

Previous $1.11 Million 2.99%

% of portfolio

0.33%

Previous 0.34%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $5,041 - $5,712	-182 Reduced 0.46%	39,344 $1.14 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $172,348 - $201,960	6,823 Added 20.86%	39,526 $1.11 Million
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $137,708 - $158,133	5,319 Added 19.42%	32,703 $907,000
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $369,347 - $479,741	14,135 Added 106.69%	27,384 $788,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $22,783 - $26,632	710 Added 5.66%	13,249 $439,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $1,625 - $1,880	45 Added 0.36%	12,539 $459,000
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $25,288 - $32,921	642 Added 5.42%	12,494 $509,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $2,087 - $2,725	50 Added 0.42%	11,852 $607,000
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $4,376 - $5,342	-100 Reduced 0.84%	11,802 $516,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $4,653 - $5,517	-100 Reduced 0.83%	11,902 $624,000
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $57,919 - $71,769	-1,266 Reduced 9.54%	12,002 $621,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $2,148 - $3,185	-52 Reduced 0.39%	13,268 $783,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $118,927 - $152,772	-3,030 Reduced 18.53%	13,320 $572,000
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $25,567 - $28,964	-712 Reduced 4.17%	16,350 $640,000
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $40,188 - $45,324	1,200 Added 7.57%	17,062 $618,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $5,020 - $6,384	-150 Reduced 0.94%	15,862 $584,000
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $1,587 - $1,862	-50 Reduced 0.31%	16,012 $587,000
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $4,066 - $4,932	-135 Reduced 0.83%	16,062 $525,000
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $5,406 - $7,723	-200 Reduced 1.22%	16,197 $528,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $95,204 - $108,045	2,892 Added 21.41%	16,397 $642,000
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $4,386 - $5,687	135 Added 1.01%	13,505 $485,000
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $13,125 - $14,420	350 Added 2.69%	13,370 $568,000
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $34,470 - $41,810	-1,000 Reduced 7.13%	13,020 $574,000
Q1 2018 May 08, 2018	BUY	$31.91 - $37.02 $17,103 - $19,842	536 Added 3.98%	14,020 $498,000
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $21,619 - $22,938	-650 Reduced 4.6%	13,484 $488,000
Q3 2017 Nov 08, 2017	SELL	$31.0 - $34.15 $9,300 - $10,245	-300 Reduced 2.08%	14,134 $505,000
Q2 2017 Aug 15, 2017	BUY	N/A	14,434	14,434 $485,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Account

Roberts Glore & CO Inc Pfizer Inc Transaction History